SGX-listed New Silkroutes Group has acquired two Shanghai-based makers of medical consumables for a consideration of S$65 million ($49.3 million), it announced in a stock exchange filing on Friday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $52.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at firstname.lastname@example.org